| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 156 | 1,680 | 820 | $90 | $307K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 184 | 1,750 | 870 | $70 | $254.4K |
| 99391 | Preventive medicine services are provided to individuals who are not in need of any immediate medical attention, but need to undergo a periodic health checkup as a preventive measure. Well–baby… | 140 | 270 | 600 | $90 | $159.1K |
| 99392 | Preventive medicine services are provided to individuals who are not in need of any immediate medical attention, but need to undergo a periodic health checkup as a preventive measure. Well–baby… | 130 | 280 | 470 | $100 | $140.8K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 448 | 720 | 120 | $150 | $94.5K |
| 99393 | The provider performs an established well–patient visit for a child who is between the ages of 5 and 11. | 154 | 290 | 200 | $90 | $72.1K |
| 87426 | The lab analyst performs an immunoassay to qualitatively or semiquantitatively evaluate the patient blood specimen for antigens of severe acute respiratory syndrome coronavirus such as SARS–CoV–2,… | 161 | 290 | 260 | $40 | $69.7K |
| 99394 | The provider performs an established well–patient visit for an adolescent who is between the ages of 12 and 17. | 147 | 270 | 90 | $100 | $35.5K |
| 87804 | The analyst performs an immunoassay with direct optical, meaning visual, observation to detect influenza, also called flu, in a patient sample, typically a throat or nasal swab or nasal washings. | 245 | 550 | 220 | $30 | $31.9K |
| 87428 | The lab analyst performs an immunoassay to qualitatively or semiquantitatively evaluate the patient specimen for antigens of severe acute respiratory syndrome (SARS) coronavirus, such as SARS–CoV–2… | 85 | 130 | 200 | $30 | $27.3K |